As healthcare is becoming increasingly personalized, genetic testing has come to play an important role in helping physicians better understand how individual patients may respond to certain treatments. Recently, America’s HealthShare partnered with Tempus to offer its Members access to genetic testing designed to support more personalized approaches to cancer and mental health treatment.
How Tempus Treatment Works
For patients facing cancer, Tempus offers comprehensive genomic testing that examines genetic material, including DNA and RNA. Using next-generation sequencing technology, these tests can identify specific genetic alterations that may influence how a cancer develops or behaves. The resulting information can help physicians evaluate potential treatment options and, in some cases, identify clinical trial opportunities that may be appropriate for a patient. The process begins when a physician orders testing as part of a patient’s treatment plan.
Depending on the circumstances, a blood or saliva sample can be collected at a medical office or at home and sent to Tempus. Tempus will then analyze the sample and provide the results to the patient’s physician, who can discuss what the findings may mean and how they could influence the next steps in care. To eliminate unnecessary stress for patients, Tempus will bill directly to America’s HealthShare, removing an extra step in the process.
Genetic Testing for Mental Health Care
Genetic testing may also provide useful information for people receiving mental health treatment. Through pharmacogenomics, commonly called PGx, genetic information can help physicians understand how an individual’s body may metabolize certain medications. This information may assist providers when selecting or managing medications and developing a treatment plan tailored to the patient.
For the Tempus nP mental health test, patients provide a saliva sample either in a clinic or at home when ordered by a healthcare provider. The collection process takes approximately five to ten minutes, and providers generally receive the results of Tempus’ analysis in about two weeks. Importantly, genetic testing is intended to support, not replace, the judgment of a qualified healthcare professional. Treatment decisions should consider the patient’s complete medical history and individual circumstances.
By incorporating genetic testing into a treatment plan, patients can have further insight into how to better approach their care. Like any other new treatment, it’s important to consult with your primary care specialist to make sure this is a useful option for you.
America’s HealthShare is Here for You
At America’s HealthShare, we are committed to providing our members and their families with affordable healthcare. We believe that families should not have to choose between providing their loved ones with quality medical care and covering essential household expenses.
For more information about how you can join the America’s HealthShare community, please check pricing online or give our Member Care team a call today at (580) AMERI-HS.